NCT00336687

Brief Summary

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
322

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2005

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 14, 2006

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2006

Completed
Last Updated

March 29, 2010

Status Verified

March 1, 2010

First QC Date

June 13, 2006

Last Update Submit

March 26, 2010

Conditions

Thrombopenia

Keywords

ThrombopeniaReanimationThrombopenia in reanimation

Outcome Measures

Primary Outcomes (1)

  • Epidemiology of Thrombopenia and its consequences.

    in reanimation

Secondary Outcomes (1)

  • The impact of cost and mortality of Thrombopenia in reanimation.

    in reanimation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of Reanimation

You may qualify if:

  • Thrombopenia in reanimation

You may not qualify if:

  • Pregnancy
  • Contraindication of myelogram

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clermont-Ferrand University Hospital

Clermont-Ferrand, Auvergne, 63000, France

Location

MeSH Terms

Conditions

Thrombocytopenia

Condition Hierarchy (Ancestors)

Blood Platelet DisordersHematologic DiseasesHemic and Lymphatic DiseasesCytopenia

Study Officials

  • Fabrice Thiolliere, Dr

    University Hospital, Clermont-Ferrand

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 13, 2006

First Posted

June 14, 2006

Study Start

July 1, 2005

Study Completion

November 1, 2006

Last Updated

March 29, 2010

Record last verified: 2010-03

Locations

FR(1)